Hello, Guest
Login
Sign Up
 
 

Stocks Declined: American Eagle Outfitters (NYSE:AEO), Genworth Financial Inc (NYSE:GNW), Edwards Lifesciences Corp(NYSE:EW)

 
 
Repost This

Dallas, TX -- (SBWIRE) -- 03/20/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

American Eagle Outfitters (NYSE:AEO) shares declined 3.33% and closed at $19.48. The company, on Mar. 6, said it will close approximately 15-20 stores in 2013 * Exec says early spring mall traffic "not been as robust as we would like" * Exec says opening new mainline stores in underserved markets including Miami and New York, and "aggressively" expanding factory store growth.
Additionally, the company, on Mar. 6, said it said it earned $94.8 million, or 47 cents per share, last quarter, as compared with a profit of $51.3 million, or 26 cents a share, a year earlier. Excluding one-time items, it earned 55 cents a share, trailing consensus estimates from analysts by a penny. Net revenue rose 9% to $1.12 billion, matching the Street’s view. Same-store sales gained 4%, compared with an 11% jump in the year-earlier period.

Get Latest News, Updates on AEO Here

Genworth Financial Inc (NYSE:GNW) shares fell 3.26% to $10.10. GNW’s stock was upgraded by equities research analysts at Scotiabank from an “underperform” rating to a “sector outperform” rating in a research note issued to investors this month.
Additionally, the company, on Mar. 6, said it is suspending sales of coverage to individuals in California as it works to get regulatory approval for a new product that raises prices and reduces benefits for policyholders.

Is GNW a Strong Buying Opportunity After The Recent Slump? Find out Here

Edwards Lifesciences Corp(NYSE:EW) shares fell 3.14% and closed at $78.66 after equities research analysts at Credit Suisse lowered their price target on shares of EW from $96.00 to $88.00 in a research note issued to investors on Mar. 19. The firm currently has a “neutral” rating on the stock.
Additionally, the company, on Mar. 11, said that patients who were implanted with its new Sapien XT heart valve did about as well as patients who received an older version of the valve.

Is EW Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.